Lentitek has secured £700,000 in private funding from Equity Gap, bringing its total investment to £1m in the last six months.
This follows a £300,000 Innovate UK grant awarded recently, accelerating the development and commercialisation of its viral vector technology for next-generation cancer treatments.
Read more HERE.
